Company evaluating systemic recombinant human DNase I in combination with anti-CD19 CAR T cells targeting lymphoma patients ...

Ambrosia Biosciences Inc. ("Ambrosia"), today announced preclinical data supporting its small molecule GLP-1 receptor agonist ...

Shares of Sagimet Biosciences Inc. (SGMT) have been struggling lately and have lost 18.1% over the past four weeks. However, ...

First Product Revenue Expected This Month, Opening New Commercial Chapter for Women's Health Innovator Limited-Time Launch Offer: 30% Off + Free ...

Jade Biosciences (JBIO) on Wednesday said it intends to offer shares of common stock and, in lieu of common stock for certain investors, pre-funded warrants in an underwritten public offering. The ...

Harvard Bioscience, Inc. will release its financial results for the fourth quarter of 2024 on March 12, 2025, before the market opens, and will host a conference call at 8:00 a.m. Eastern Time to ...

Jade Biosciences Inc. company and executive profile by Barron's. View the latest JBIO company infomation and executive bios.

On May 19, Wolfe Research initiated Tyra Biosciences, Inc. (NASDAQ:TYRA) with a Peer Perform rating and no price target.

Octave Bioscience, Inc. is a commercial stage precision care company pioneering biomarker-driven solutions for neurodegenerative diseases, with initial focus on Multiple Sclerosis, and Parkinson’s ...

Neurocrine Biosciences, Inc. (NBIX) 46th Annual William Blair Growth Stock Conference June 2, 2026 11:40 AM EDTCompany ParticipantsMatthew Abernethy - ...

View Tyra Bioscience, Inc TYRA stock quote prices, financial information, real-time forecasts, and company news from CNN.

View Aura Biosciences Inc AURA stock quote prices, financial information, real-time forecasts, and company news from CNN.